These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 8224482

  • 1. Triglyceride-rich particles, high-density lipoprotein and their pharmacological modulation.
    Bard JM, Fruchart JC.
    Biochem Soc Trans; 1993 Aug; 21 ( Pt 3)(3):647-9. PubMed ID: 8224482
    [No Abstract] [Full Text] [Related]

  • 2. Pharmacological modulation of ApoA- and ApoB-containing lipoproteins.
    Bard JM.
    Prog Lipid Res; 1991 Aug; 30(2-3):267-74. PubMed ID: 1823945
    [No Abstract] [Full Text] [Related]

  • 3. Effects of simvastatin and cholestyramine on lipoprotein profile in hyperlipidaemia of nephrotic syndrome.
    Rabelink AJ, Hené RJ, Erkelens DW, Joles JA, Koomans HA.
    Lancet; 1988 Dec 10; 2(8624):1335-8. PubMed ID: 2904053
    [Abstract] [Full Text] [Related]

  • 4. Intestinal lipoprotein assembly in apobec-1-/- mice reveals subtle alterations in triglyceride secretion coupled with a shift to larger lipoproteins.
    Xie Y, Nassir F, Luo J, Buhman K, Davidson NO.
    Am J Physiol Gastrointest Liver Physiol; 2003 Oct 10; 285(4):G735-46. PubMed ID: 12816761
    [Abstract] [Full Text] [Related]

  • 5. Effects of simvastatin and cholestyramine in familial and nonfamilial hypercholesterolemia. Multicenter Group I.
    Stein E, Kreisberg R, Miller V, Mantell G, Washington L, Shapiro DR.
    Arch Intern Med; 1990 Feb 10; 150(2):341-5. PubMed ID: 2405804
    [Abstract] [Full Text] [Related]

  • 6. Essential hyperlipemia with xanthomatosis: effects of cholestyramine and clofibrate.
    Roe DA.
    Arch Dermatol; 1968 Apr 10; 97(4):436-45. PubMed ID: 5643239
    [No Abstract] [Full Text] [Related]

  • 7. Effect of fluvastatin on plasma apolipoprotein-B-containing particles, including lipoprotein(a). European Fluvastatin Study Group.
    Dallongeville J, Fruchart JC, Pfister P, Bard JM.
    J Intern Med Suppl; 1994 Apr 10; 736():95-101. PubMed ID: 7986315
    [Abstract] [Full Text] [Related]

  • 8. Treatment of essential hyperlipidaemia.
    Fredrickson DS, Levy RI.
    Lancet; 1970 Jan 24; 1(7639):191-2. PubMed ID: 4189261
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of fluvastatin on intermediate density lipoprotein (remnants) and other lipoprotein levels in hypercholesterolemia.
    Broyles FE, Walden CE, Hunninghake DB, Hill-Williams D, Knopp RH.
    Am J Cardiol; 1995 Jul 13; 76(2):129A-135A. PubMed ID: 7604788
    [Abstract] [Full Text] [Related]

  • 13. Changes in plasma apolipoprotein B-containing lipoparticle levels following therapy with fluvastatin and cholestyramine. European Fluvastatin Study Group.
    Bard JM, Ose L, Hagen E, Duriez P, Pfister P, Fruchart JC, Dallongeville J.
    Am J Cardiol; 1995 Jul 13; 76(2):65A-70A. PubMed ID: 7604802
    [Abstract] [Full Text] [Related]

  • 14. [Changes in the levels and composition of lipoproteins and apolipoproteins of blood plasma in patients with ischemic heart disease after hemosorption].
    Torkhovskaia TI, Khalilov EM, Oleĭnik IA, Kliuchnikova ZhI, Klimov AN.
    Kardiologiia; 1989 Oct 13; 29(10):60-4. PubMed ID: 2615161
    [Abstract] [Full Text] [Related]

  • 15. Hyperlipidemia in stable renal transplant recipients.
    Ong-Ajyooth L, Sirisalee K, Shayakul C, Vareesangthip K, Vasuvattakul S, Chirawong P, Vanichakarn S, Nimmannit S, Ong-Ajyooth S, Nilwarangkur S.
    Transplant Proc; 1994 Aug 13; 26(4):2062-4. PubMed ID: 8066670
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Lipids, lipoproteins and apolipoproteins AI, AII, B, CII, CIII and E in newborns.
    Averna MR, Barbagallo CM, Di Paola G, Labisi M, Pinna G, Marino G, Dimita U, Notarbartolo A.
    Biol Neonate; 1991 Aug 13; 60(3-4):187-92. PubMed ID: 1797121
    [Abstract] [Full Text] [Related]

  • 19. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
    Ginsberg HN, Le NA, Goldberg IJ, Gibson JC, Rubinstein A, Wang-Iverson P, Norum R, Brown WV.
    J Clin Invest; 1986 Nov 13; 78(5):1287-95. PubMed ID: 3095375
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.